HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Liver cirrhosis in an infant with Chanarin-Dorfman syndrome caused by a novel splice-site mutation in ABHD5.

AbstractUNLABELLED:
We described a Turkish girl with Chanarin-Dorfman syndrome who developed liver cirrhosis in the early infancy. She had all the clinical features of Chanarin-Dorfman syndrome such as ichthyosis, Jordan's anomaly, fatty liver disease and mild ectropion. The diagnosis was confirmed with a novel ABHD5 mutation. Liver steatosis or steatohepatitis with or without hepatomegaly is the predominant finding of Chanarin-Dorfman syndrome. Cirrhosis has been reported in patients with long-duration disease.
CONCLUSION:
Local factors or dysfunction of local proteins such as mutations or polymorphisms in hepatic microsomal lipase and arylacetamide deacetylase may contribute the severity of liver involvement, and steatosis may progress to cirrhosis in the early infancy in Chanarin-Dorfman syndrome.
AuthorsM Cakir, C Bruno, A Cansu, U Cobanoglu, E Erduran
JournalActa paediatrica (Oslo, Norway : 1992) (Acta Paediatr) Vol. 99 Issue 10 Pg. 1592-4 (Oct 2010) ISSN: 1651-2227 [Electronic] Norway
PMID20528790 (Publication Type: Journal Article)
Copyright© 2010 The Author(s)/Journal Compilation © 2010 Foundation Acta Paediatrica.
Chemical References
  • RNA Splice Sites
  • 1-Acylglycerol-3-Phosphate O-Acyltransferase
  • ABHD5 protein, human
Topics
  • 1-Acylglycerol-3-Phosphate O-Acyltransferase (genetics)
  • Child, Preschool
  • Consanguinity
  • Fatty Liver (etiology)
  • Female
  • Humans
  • Ichthyosiform Erythroderma, Congenital (diagnosis, diet therapy, genetics)
  • Lipid Metabolism, Inborn Errors (diagnosis, diet therapy, genetics)
  • Liver Cirrhosis
  • Muscular Diseases (diagnosis, diet therapy, genetics)
  • Mutation
  • RNA Splice Sites (genetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: